Liao Zhicong, Wang Xiaojun, Liang Hongwei, Yu Ao, Ur Rehman Uzair, Fan Qian, Hu Yue, Wang Chen, Zhou Zhen, Wang Tao
Department of Thoracic and Cardiovascular Surgery, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, 210008, China.
Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu, 210009, China.
Cancer Med. 2017 Dec;6(12):2957-2965. doi: 10.1002/cam4.1214. Epub 2017 Oct 16.
Nonreceptor tyrosine kinase c-Src, also known as Src, is a potent oncogene involved in a series of biological processes including cell growth, differentiation, and apoptosis; however, its expression pattern and function in esophageal cancer is poorly addressed. In this study, abnormal overexpression of Src protein was observed in esophageal cancer tissues, which fuelled the speculation that microRNA-mediated posttranscriptional regulatory mechanism might be involved. Bioinformatic analyses were applied to identify miRNAs that could potentially target Src. miR-1 was predicted and further validated as a direct repressor of Src. Moreover, we manipulated knockdown and overexpression experiment on TE-1 and TE-10 cells to demonstrate miR-1 suppressed proliferation and promoted apoptosis in esophageal cancer cells by inhibiting Src. Taken together, this study underlines a negative regulatory mechanism in which miR-1 serves as a suppressor of Src in esophageal cancer cells and may provide insights into novel therapeutic approaches for esophageal cancer.
非受体酪氨酸激酶c-Src,也称为Src,是一种强效癌基因,参与包括细胞生长、分化和凋亡在内的一系列生物学过程;然而,其在食管癌中的表达模式和功能鲜少被探讨。在本研究中,在食管癌组织中观察到Src蛋白异常过表达,这引发了一种推测,即可能涉及微小RNA介导的转录后调控机制。应用生物信息学分析来鉴定可能靶向Src的微小RNA。预测miR-1并进一步验证其为Src的直接抑制因子。此外,我们在TE-1和TE-10细胞上进行了敲低和过表达实验,以证明miR-1通过抑制Src来抑制食管癌细胞的增殖并促进其凋亡。综上所述,本研究强调了一种负调控机制,其中miR-1作为食管癌细胞中Src的抑制因子,可能为食管癌的新治疗方法提供思路。